In Brief: Ex-Bard execs' trial
This article was originally published in The Gray Sheet
Executive Summary
Ex-Bard execs' trial: Jury deliberation in the conspiracy case against five former Bard officials begins Aug. 17. The five remaining defendants in the trial -- former Bard CEO George Maloney, former Bard Group Vice President David Prigmore, former USCI President John Cvinar, former USCI Director of Regulatory Affairs and Quality Assurance Lee Leichter and former USCI Director of Regulatory Affairs Kenneth Thurston -- are facing criminal conspiracy charges related to alleged actions such as failing to make needed premarket filings to FDA, lying to the agency in the course of obtaining device approvals and failing to report injuries resulting from product failures. Closing arguments in the case were presented Aug. 15-16. The ex-Bard officials' lawyers rested their case without presenting a defense ("The Gray Sheet" Aug. 14, p. 33)...